Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Dec' 24 |
Sep' 24 |
Jun' 24 |
Mar' 24 |
Dec' 23 |
Sales |
1,101.92 |
1,128.91 |
1,077.27 |
926.07 |
1,085.29 |
Operating profit |
336.33 |
302.91 |
315.83 |
227.15 |
327.18 |
Interest |
2.48 |
0.73 |
0.72 |
1.42 |
2.36 |
Gross profit |
367.08 |
342.52 |
343.48 |
259.41 |
338.55 |
EPS (Rs) |
20.14 |
18.75 |
18.83 |
12.88 |
17.42 |
Quarterly
results in details
|
Dec' 24 |
Sep' 24 |
Jun' 24 |
Mar' 24 |
Dec' 23 |
Other income |
33.23 |
40.34 |
28.37 |
33.68 |
13.73 |
Stock adjustment |
4.00 |
17.60 |
-25.08 |
-59.42 |
31.01 |
Raw material |
210.14 |
207.09 |
238.41 |
259.03 |
239.04 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
245.71 |
241.65 |
265.68 |
215.97 |
216.41 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
305.74 |
359.66 |
282.43 |
283.34 |
271.65 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
34.93 |
33.32 |
32.92 |
33.47 |
33.41 |
Taxation |
79.70 |
74.22 |
74.53 |
63.25 |
84.99 |
Net profit / loss |
252.45 |
234.98 |
236.03 |
162.69 |
220.15 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
25.07 |
25.07 |
25.07 |
25.27 |
25.27 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
30.52 |
26.83 |
29.32 |
24.53 |
30.15 |
GPM (%) |
32.34 |
29.29 |
31.07 |
27.03 |
30.80 |
NPM (%) |
22.24 |
20.10 |
21.35 |
16.95 |
20.03 |